Chronic kidney diseases currently affect around 4.3 million people and are responsible for approximately 1.2 million deaths each year globally.

Researchers study these diseases using chronic kidney disease samples to understand disease progression, identify biomarkers, and develop targeted therapies.

At Bay Biosciences, we provide high-quality kidney disease research samples to help scientists better understand chronic renal failure and other forms of kidney dysfunction

Understanding Chronic Kidney Disease (CKD)

Chronic kidney disease (CKD) is the gradual loss of kidney function that develops over time.

In the early stages, most people have no symptoms at all.

Eventually, however, the condition can cause problems such as high blood pressure and fluid-related swelling throughout the body.

As the disease advances, it can eventually lead to kidney failure.

Chronic Kidney Disease Samples for Research

Symptoms of Chronic Kidney Disease (CKD)

Most people with CKD are unaware they have it because symptoms do not usually appear in the early stages.

By the time a person notices something is wrong, the disease has often already reached an advanced stage, and the kidney damage is irreversible.

Common symptoms of CKD include:

Stages of Chronic Kidney Disease (CKD)

Doctors use the glomerular filtration rate (GFR) to determine how advanced a person’s CKD is.

The GFR measures how well the kidneys filter waste from the blood.

Stage 1:

In stage 1, GFR is at least 90 ml/min per 1.73 m². Kidney function appears normal, but there are signs of kidney damage, such as protein in the urine or physical damage visible on imaging.

Stage 2:

Stage 2 means GFR is between 60 and 89 ml/min per 1.73 m². The kidneys are still working fairly well, but additional signs of damage are present. Patients with stage 1 or 2 CKD can discuss kidney-protective medications with their doctor.

Stage 3:

At stage 3, GFR drops to between 30 and 59 ml/min per 1.73 m², indicating moderate kidney damage. Stage 3 is divided into two sub-stages:

Stage 3a:

GFR of 45 to 59 ml/min per 1.73 m²

Stage 3b:

GFR of 30 to 44 ml/min per 1.73 m²

Stage 4:

By stage 4, GFR is between 15 and 29 ml/min per 1.73 m². The kidneys are moderately to severely damaged. This is a serious stage and the last step before kidney failure. Symptoms become more noticeable, and complications such as anemia and bone disease are more likely.

Stage 5:

Stage 5 means GFR has fallen to 15 ml/min per 1.73 m² or less. At this point, the kidneys have either failed or are close to failing.

Causes of Chronic Kidney Disease (CKD)

  • Diabetes
  • High blood pressure
  • Certain Autoimmune conditions
  • Polycystic kidney disease and other inherited kidney disorders
  • Vesicoureteral reflux
  • Certain medications, including lithium, high doses of ibuprofen etc

Risk Factors of Chronic Kidney Disease (CKD)

  • A family history of kidney disease
  • Being over 60 years of age, as CKD is far more common in older adults
  • Obesity
  • Smoking
  • Heart disease
  • Previous kidney damage

Diagnosis of Chronic Kidney Disease (CKD)

When diagnosing CKD, a doctor reviews symptoms, checks for risk factors, and may order several tests.

They may also recommend a urine test, which can check for albumin, a protein that appears in urine when the kidneys get damaged.

Similarly, kidney scans can help the doctor see the size and shape of the kidneys.

Biopsies are also considered to be a valuable tool for the diagnosis of kidney disease.

Lastly, a GFR test is also used, which measures how well the kidneys filter waste from the blood.

Treatment of Chronic Kidney Disease (CKD)

Kidney damage caused by chronic kidney disease (CKD) is usually permanent, but treatment can help manage symptoms and slow disease progression.

Doctors often treat CKD-related anemia with erythropoiesis-stimulating agents (ESAs), which help the body produce more red blood cells.

Managing blood pressure is another important part of treatment. Medications such as ACE inhibitors or ARBs, along with regular exercise and dietary changes, can help protect kidney function.

In addition, people with CKD may need to limit foods high in phosphate, including dairy products, red meat, eggs, and fish. Since CKD can also lower vitamin D levels and weaken bones, some patients may require vitamin D supplements.

Patients are also advised to reduce salt and control fluid intake to prevent swelling, high blood pressure, and heart complications.

A balanced kidney-friendly diet can further reduce strain on the kidneys by controlling protein, salt, potassium, and phosphorus intake.

Finally, in advanced stages of CKD, dialysis or kidney transplantation may become necessary when the kidneys can no longer filter waste effectively.

Applications of Chronic Kidney Disease Clinical Samples

1. Biomarker discovery:

Identifying biological signals that indicate the onset or progression of CKD

2. Drug development:

Testing new therapies that target specific pathways involved in renal dysfunction

3. Inflammatory kidney disease studies:

Investigating the role of immune activation and inflammation in CKD

4. Kidney biomarker discovery:

Finding measurable indicators in blood and urine that reflect kidney health

5. Precision medicine:

Developing individualized treatment approaches based on a patient’s unique biology

6. Comparative studies:

Analyzing differences between CKD patients at various stages and healthy control samples

The use of well-characterized kidney disorder biospecimens with complete clinical data helps researchers draw more reliable and reproducible conclusions.

Similarly, access to kidney renal failure samples from diverse patient populations also supports more inclusive and generalizable research outcomes.

Importance of High-Quality Biospecimens

The quality of biospecimens directly affects the accuracy and reliability of research findings.

At Bay Biosciences we follow strict collection, processing, and storage protocols to maintain the integrity of every sample.

These quality control measures support greater confidence in research outcomes, whether scientists are working on kidney biomarker discovery, inflammatory kidney disease studies, or broader nephrology clinical studies.

Supporting Your Research with Bay Biosciences

Bay Biosciences offers a comprehensive range of chronic kidney disease samples and kidney disorder biospecimens to support your research projects, including:

If you have specific research requirements or need customized kidney disorder biospecimens to support your renal dysfunction research, our team is ready to help.

Please feel free to reach out to us.